切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2013, Vol. 02 ›› Issue (05) : 246 -250. doi: 10.3877/cma.j.issn.2095-3224.2013.05.11.

所属专题: 文献

综述

Micro RNAs in colorectal cancer
王锡山1,()   
  1. 1. 150086 哈尔滨医科大学附属第二医院结直肠肿瘤外科 哈尔滨医科大学大肠癌研究所
  • 收稿日期:2013-08-07 出版日期:2013-10-25
  • 通信作者: 王锡山
  • Received:2013-08-07 Published:2013-10-25
引用本文:

王锡山. Micro RNAs in colorectal cancer[J]. 中华结直肠疾病电子杂志, 2013, 02(05): 246-250.

[1]
Jemal A,Siegel R,Ward E,et al.Cancer Statistics,2008.CA Cancer Clin,2008,58:71-96.
[2]
Grothey A,Schmoll HJ.New chemotherapy approaches in colorectal cancer.Curr Opin Oncol,2001,13:27586.
[3]
Gupta GP,Massague J.Cancer metastasis:building a framework.Cell,2006,127:679-695.
[4]
Fidler IJ.The pathogenesis of cancer metastasis:the 'seed and soil’ hypothesis revisited.Nat Rev Cancer,2003,3:453-458.
[5]
Mani SA,Yang J,Brooks M,et al.Mesenchyme Forkhead 1(FOXC2)plays a key role in metastasis and is associated with aggressive basal-like breast cancers.Proc Natl Acad Sci U S A,2007,104:10069-10074.
[6]
Calin GA,Sevignani C,Dumitru CD,et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc Natl Acad Sci U S A,2004,101:2999-3004.
[7]
Bhardwaj A,Singh S,Singh AP MicroRNA-based Cancer Therapeutics:Big Hope from Small RNAs.Mol Cell \'Pharmacol,2010,2:213-219.
[8]
Vickers MM,Bar J,Gorn-Hondermann I,et al.Stage-dependent differential expression of microRNAs in colorectal cancer:potential role as markers of metastatic disease.Clin Exp Metastasis,2012,29:123-132.
[9]
Ha TY.microRNAs in Human Diseases:From Cancer to Cardiovascular Disease.Immune Netw,2011.11:135-154.
[10]
Schetter AJ,Leung SY,Sohn JJ,et al.MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.JAMA,2008,299:425-436.
[11]
Valadi H,Ekstrom K,Bossios A,et al.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.Nat Cell Biol,2007,9(6):654-659.
[12]
Skog J,Wurdinger T,van Rijn S,et al.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat Cell Biol,2008,10(12):1470-1476.
[13]
Chen X,Ba Y,Ma L,et al.Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases.Cell Res,2008,18(10):997-1006.
[14]
Lawrie CH,Gal S,Dunlop HM,et al.Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.Br J Haematol,2008,141(5):672-675.
[15]
Gilad S,Meiri E,Yogev Y,et al.Serum microRNAs are promising novel biomarkers.PLoS One,2008,3(9):e3148.
[16]
Ventura A,Jacks T.MicroRNAs and cancer:short RNAs go a long way.Cell,2009.136:586-591.
[17]
Mitchell PS,Parkin RK,Kroh EM,et al.Circulating microRNAs as stable blood-based markers for cancer detection.Proc Natl Acad Sci USA,2008,105(30):10513-10518.
[18]
Chang KH,Miller N,Kheirelseid EA,Lemetre C,et al.MicroRNA signature analysis in colorectal cancer:Identification of expression profiles in stage II tumors associated with aggressive disease.Int J Colorectal Dis,2011,26:1415-1422.
[19]
Zhang P,Ma Y,Wang F,et al.Comprehensive gene and microRNA expression profiling reveals the crucial role of hsa-let-7i and its target genes in colorectal cancer metastasis.Mol Biol Rep,2012,39:1471-1478.
[20]
Chaffer C.L.,Weinberg R.A..A perspective on cancercell metastasis.Science,2011,331(6024):1559-1564.
[21]
Hanahan D.,Weinberg R.A..Hallmarks of cancer:thenext generation.Cell,2011,144(5):646-674.
[22]
Folkman J,Klagsbrun M.Angiogenic factors.Science,1987,235(4787):442-447.
[23]
Jain RK.Normalization of tumor vasculature:an emerging concept in antiangiogenic therapy.Science,2005,307:58-62.
[24]
Poliseno L,Tuccoli A,Mariani L,et al.MicroRNAs modulate the angiogenic properties of HUVECs.Blood,2006,108:3068-3071.
[25]
Bonauer A,Carmona G,Iwasaki M,et al.MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.Science,2009,324:1710-1713.
[26]
Sundaram P,Hultine S,Smith LM,et al.p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers.Cancer Res,2011,71:7490-7501.
[27]
Zhu N,Zhang D,Chen S,et al.Endothelial enriched microRNAs regulate angiotensin II-induced endothelial ingflammation and migration.Atherosclerosis,2011,215:286-293.
[28]
Cheng H,Zhang L,Cogdell DE,et al.Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.PLoS One,2011,6:e17745.
[29]
Fish JE,Santoro MM,Morton SU,et al.miR-126 regulates angiogenic signaling and vascular integrity.Dev Cell,2008,15:272-284.
[30]
Ota T,Doi K,Fujimoto T,et al.KRAS Up-regulates the Expression of miR-181a,miR-200c and miR-210 in a Threedimensional-specific Manner in DLD-1 Colorectal Cancer Cells.Anticancer Res,2012,32:2271-2275.
[31]
Guo ST,Jiang CC,Wang GP,et al.MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.Oncogene,2012,32(15):1910-1920.
[32]
Wang X,Wang J,Ma H,et al.Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.Med Oncol,2012,29:919-927.
[33]
Friedl P,Alexander S.Cancer invasion and the microenvironment:plasticity and reciprocity.Cell,2011,147:992-1009.
[34]
Bierie B,Moses HL.Tumour microenvironment:TGFbeta:the molecular Jekyll and Hyde of cancer.Nat Rev Cancer,2006,6:506-520.
[35]
Wang CJ,Stratmann J,Zhou ZG,Sun XF.Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage,and affects cell migration and invasion in HCT-116 colon cancer cells.BMC Cancer,2010,10:616.
[36]
Kanaan Z,Rai SN,Eichenberger MR,Barnes C,et al.Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer.Hum Mutat,2012,33:551-560.
[37]
Hur K,Toiyama Y,Takahashi M,et al.MicroRNA-200c modulates epithelial-to-mesenchymal transition(EMT)in human colorectal cancer metastasis.Gut,2013,62(9):1315-1326.
[38]
Xu XT,Xu Q,Tong JL,Zhu et al.MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.Br J Cancer,2012,106:1320-1330.
[39]
Arndt GM,Dossey L,Cullen LM,et al.Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.BMC Cancer,2009,9:374.
[40]
Fu J,Tang W,Du P,Wang G,et al.Identifying MicroRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.BMC Syst Biol,2012,6:68.
[41]
Huang Z,Huang D,Ni S,et al.Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.Int J Cancer,2010,127:118-126.
[42]
Wang LG,Gu J.Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.Cancer Epidemiol,2012,36:e61-7.
[43]
Zhang J,Xiao Z,Lai D,et al.miR-21,miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer.Br J Cancer,2012,107:352-359.
[44]
Bockhorn M,Jain RK,Munn LL.Active versus passive mechanisms in metastasis:do cancer cells crawl into vessels,or are they pushed? Lancet Oncol,2007,8:444-448.
[45]
Lu LF,Liston A.MicroRNA in the immune system,microRNA as an immune system.Immunology,2009,127:291-298.
[46]
Valastyan S,Reinhardt F,Benaich N,et al.A pleiotropically acting microRNA,miR-31,inhibits breast cancer metastasis.Cell,2009,137:1032-1046.
[47]
Penna E,Orso F,Cimino D,et al.MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.EMBO J,2011,30:1990-2007.
[48]
Asangani IA,Rasheed SA,Nikolova DA et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion,intravasation and metastasis in colorectal cancer.Oncogene,2008,27:2128-2136.
[49]
Wang K,Zhang S,Marzolf B,Troisch,et al.Circulating microRNAs,potential biomarkers for drug-induced liver injury.Proc Natl Acad Sci USA,2009,106:4402-4407.
[50]
Harris TA,Yamakuchi M,Ferlito M,et al.MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1.Proc Natl Acad Sci USA,2008,105:1516-1521.
[51]
Lu LF,Liston A.MicroRNA in the immune system,microRNA as an immune system.Immunology,2009,127:291-298.
[52]
Xu XT,Xu Q,Tong JL,et al.MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.Br J Cancer,2012,106:1320-1330.
[53]
Ma YL,Zhang P,Wang F,et al.Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b.J Cell Mol Med,2011,15:1941-1954.
[54]
Sundaram P,Hultine S,Smith LM,et al.p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers.Cancer Res,2011,71:7490-7501.
[55]
Paget S.The distribution of secondary growths in cancer of the breast.Cancer Metastasis Rev,1989,8:98-101.
[56]
Dieter SM,Ball CR,Hoffmann CM,et al.Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.Cell Stem Cell,2011,9:357-365.
[57]
Chen RH,Chen HY,Lin YM,et al.miR-103/107 promotes metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.Cancer Res,2012,72:3631-3641.
[58]
Hudson,J.D.,Shoaibi,M.A.,Maestro,et al.A proinflammatory cytokine inhibits p53 tumor suppressor activity.J.Exp.Med,1999,190:1375-1382.
[59]
Ohkawara,T.,Nishihira,J.,Takeda,et al.Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal,hepatic,and pancreatic disorders.J.Gastroenterol,2005,40:117-122.
[60]
He, X.-X., Chen, K., Yang, J., Li, et al.Macrophage migration inhibitory factor promotes colorectal cancer.Mol.Med, 2009,15:1-10.
[61]
Bandres, E., Bitarte, N., Arias, F., et al.microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.Clin Cancer Res, 2009b,15:2281-2290.
[62]
Toyota, M., Suzuki, H., Sasaki, Y., et al.Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.Cancer Res, 2008,68:4123-4132.
[63]
Bandres, E., Agirre, X., Bitarte, N., et al.Epigenetic regulation of microRNA expression in colorectal cancer.Int.J.Cancer, 2009,125:2737-2743.
[64]
de Krijger I,Mekenkamp LJ,Punt CJ,et al.MicroRNAs in colorectal cancer metastasis.J Pathol,2011,224:438-447.
[65]
Kahlert C,Lahes S,Radhakrishnan P,et al.Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.Clin Cancer Res,2011,17:7654-7663.
[66]
Ali S,Almhanna K,Chen W.et al.Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer.AmJ Transl Res,2010,3:28-47.
[67]
Chen, X., Guo, X., Zhang, H., et al.Role of miR-143 targeting KRAS in colorectal tumorigenesis.Oncogene, 2009,28:1385-1392.
[68]
Ng, E.K.O., Tsang, W.P., Ng, et al.MicroRNA-143 targets DNA methyltransferases3A in colorectal cancer.Br.J.Cancer, 2009,101:699-706.
[69]
Akao, Y., Nakagawa, Y., Naoe, T.let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.Biol.Pharm.Bull, 2006,29:903-906.
[70]
Dews, M., Homayouni, A., Yu, D et al.Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.Nat Genet, 2006,38:1060-1065.
[71]
Sureban, S.M., May, R., et al.Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a microRNA-dependent mechanism.Gastroenterology, 2009,137:649-659.
[72]
Nagel, R., le Sage, C., Diosdado, B., et al.Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.Cancer Res, 2008,68:5795-5802.
[73]
Fang, W., Lin, C., Zhang, H., et al.Detection of let-7a microRNA by real-time PCR in colorectal cancer:a single-centre experience from China.J.Int.Med Res, 2007,35:716-723.
No related articles found!
阅读次数
全文


摘要